Month: July 2025

FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that it distributed a letter from Chairman TJ Rodgers to all shareholders to discuss the Company’s recent warrant dividend distribution. A copy of the letter has been posted on the Company’s website here. Further Information Relating to the Warrants For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the Securities and Exchange Commission (the “SEC”) available at https://www.sec.gov and the information posted on the Company’s website at https://www.enovix.com/enovix-warrant-dividend. About Enovix Corporation Enovix is a leader in advancing lithium-ion battery...

LOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) — Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation’s leading neobanks, today announced that the Company will participate in the following upcoming investor conferences in August 2025.Oppenheimer 28th Annual Technology, Internet & Communications Conference is being held virtually on August 11-13. The Company will present at 3:45pm ET and host 1×1 meetings on August 11.Canaccord Genuity 45th Annual Growth Conference is being held on August 12-14 at the InterContinental Boston Hotel. The Company will participate in a fireside chat at 9:00am ET and host 1×1 meetings on August 13. The live event or replay can be accessed here or through the Dave investor relations website at investors.dave.com.7th Annual Needham FinTech & Digital Transformation...

CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) — Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) is pleased to announce that it will participate in the upcoming Canaccord Genuity 45th Annual Growth Conference, which is being held in Boston, MA, on August 12th and 13th, 2025. Pramod Jain, Chief Executive Officer and Vipin Khullar, Chief Financial Officer, will host one-on-one meetings at the conference and will be presenting on August 13th, 2025, at 11:30 am EDT. A live webcast and replay of the presentation will be available here and in the “Events and Presentations” section of the Company’s Investor Relations website. About CMG CMG (TSX:CMG) is a global software and consulting company that combines science and technology with deep industry expertise to solve complex subsurface and surface challenges for the...

Child Presence DetectionMagna’s Child Presence Detection technology advances occupant safety, gaining momentum with industry adoptionMagna’s integrated interior sensing systems are experiencing growing demand from multiple OEMs worldwide Interior sensing systems are essential for comprehensive and responsive vehicle safety while maintaining a positive driving experience Advanced features in Child Presence Detection technology enhance occupant safety, preventing heatstroke in vulnerable passengersAURORA, Ontario, July 29, 2025 (GLOBE NEWSWIRE) — Magna is redefining vehicle safety with its comprehensive interior sensing systems, designed to protect occupants and enhance the driving experience. Over the last 18 months, Magna’s interior sensing systems have either been awarded or begun production on five OEM programs...

OREM, Utah, July 29, 2025 (GLOBE NEWSWIRE) — SunPower (aka Complete Solaria, Inc.) (“SunPower” or the “Company”) (Nasdaq: SPWR), a solar technology, services, and installation company, today announced the Company will attend the Canaccord Genuity 45th Annual Growth Conference, on Tuesday, August 12 at the InterContinental hotel in Boston, Massachusetts. SunPower will participate in one-on-one meetings throughout the day, and Chairman and CEO Dr. T.J. Rodgers will give a company presentation at 11:30am ET. A link to the live webcast and presentation slides will be available on the Investor Relations section of the Company’s website at https://investors.sunpower.com under the “Events” section. SunPower Chairman and CEO T.J. Rodgers commented, “SunPower is in the middle of its third consecutive quarter of profitability after a four-year...

FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, today announced the launch of the 4th-generation Enphase® Energy System, featuring the IQ® Battery 10C, IQ® Meter Collar, and the IQ® Combiner 6C. This next-generation system stands out for its smaller footprint, enhanced features, easier installation, and unmatched reliability. Watch a video about the new Enphase system here. The IQ Battery 10C is the core of the 4th-generation Enphase Energy System, offering 10 kWh of usable energy and delivers 7.08 kW of continuous power, capable of supporting heavy startup loads like HVAC systems and pool pumps. Its compact form factor delivers nearly 34% greater energy density and can...

BOCA RATON, FL, July 29, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it now holds approximately 1,182,685 SOL and SOL equivalents on its balance sheet, inclusive of rewards generated through staking and onchain activities. The increase follows the Company’s purchase of 181,303 SOL between July 21 – July 28, at an average purchase price of $155.33, representing a total value of approximately $28 million. The purchases, primarily funded through proceeds from the Company’s Equity Line of Credit, included both spot and discounted locked SOL. As a result, the Company’s key performance metric, SOL per share (“SPS”), rose 12% week over week to 0.0575 as of July 28, 2025 – marking the...

Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and High-Value Crypto Treasury Transactions UNIONDALE, NY, July 29, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, will hold a Special Meeting of Shareholders on August 29, 2025, at 4:00 p.m. Eastern Time at 273 Merrick Road, Lynbrook, NY 11563. The Board of Directors has unanimously recommended shareholders vote ‘FOR’ all proposals at the upcoming Special Meeting. The Company is seeking to increase the authorized shares to 1 billion to strategically position the Company to attract high-value structured transactions and industry-leading...

A first-of-its-kind solution for women’s arousal in a proprietary topical formulation demonstrated to work where women need it most Targeted to be available by prescription in the fourth quarter of 2025 Collaboration leverages Rosy Wellness’ extensive reach and community of over 250,000 women; campaign designed to drive awareness and support women with arousal concerns SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing the gap in women’s health between promising science and real solutions, and Rosy Wellness, a pioneering digital platform focused on providing lifespan support for women, today announced the launch of the first phase of a consumer awareness campaign to support the upcoming introduction of DARE to PLAY Sildenafil Cream. DARE to...

SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for the pivotal TACTI-004 (KEYNOTE-F91) Phase III trial at the IASLC 2025 World Conference on Lung Cancer (WCLC), taking place in Barcelona, Spain, from 6-9 September 2025. The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s antigen presenting cell (APC) activator, eftilagimod alfa (efti) in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) anti-PD-1 KEYTRUDA® (pembrolizumab) and chemotherapy as first line therapy for patients with advanced or metastatic non-small cell lung cancer (1L NSCLC). The global...